DANAMECO Medical JSC

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: VN000000DNM6
VND
9,900.00
0.00 (0.00%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Million
Consolidate Quarterly Results
Jun'23
Mar'23
Dec'22
Sep'22
Jun'22
Mar'22
Dec'21
Net Sales
69,857.20
50,230.49
70,417.44
57,377.55
52,205.81
1,44,649.64
2,25,812.92
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
69,857.20
50,230.49
70,417.44
57,377.55
52,205.81
1,44,649.64
2,25,812.92
Raw Material Cost
64,541.77
55,659.59
59,854.83
64,138.53
41,764.65
1,10,249.69
1,78,896.16
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
4,822.00
3,711.88
3,445.10
3,550.69
3,892.55
4,015.26
10,435.51
Selling and Distribution Expenses
8,483.24
7,801.94
7,705.40
8,109.06
8,758.29
11,315.74
16,670.60
Other Expenses
-482.20
-371.19
-344.51
-355.07
-389.25
-401.53
-1,043.55
Total Expenditure (Excl Depreciation)
73,025.01
63,461.52
67,560.23
72,247.59
50,522.94
1,21,565.42
1,95,566.76
Operating Profit (PBDIT) excl Other Income
-3167.7999999999997
-13231
2857.2000000000003
-14870
1682.8999999999999
23084.2
30246.199999999997
Other Income
-6,322.18
-6,850.25
-18.39
769.55
-437.68
-2.51
183.33
Operating Profit (PBDIT)
-2,188.12
-6,739.16
24,974.22
-10,757.20
7,785.72
35,252.48
37,359.31
Interest
4,822.00
3,711.88
3,445.10
3,550.69
3,892.55
4,015.26
10,435.51
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
5,315.43
-5,429.10
10,562.62
-6,760.98
10,441.16
34,399.95
46,916.75
Depreciation
7,301.86
13,342.13
22,135.40
3,343.29
6,540.53
12,170.77
6,929.82
Profit Before Tax
-14,311.99
-23,793.17
-606.29
-17,651.18
-2,647.36
19,066.45
20,645.74
Tax
0.00
0.00
133.12
0.00
0.00
3,813.29
4,129.15
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-14,311.99
-23,793.17
-739.40
-17,651.18
-2,647.36
15,253.16
16,516.59
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
-14,311.99
-23,793.17
-739.40
-17,651.18
-2,647.36
15,253.16
16,516.59
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-14,311.99
-23,793.17
-739.40
-17,651.18
-2,647.36
15,253.16
16,516.59
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
10000.0
Reserves
4,496.77
74,846.74
59,683.49
98,639.91
1,57,914.68
1,60,632.78
1,43,888.55
Earnings per share (EPS)
-2724.5
-4529.38
-140.76
-4032.15
-503.96
2903.63
3144.14
Diluted Earnings per share
-2724.5
-4529.38
-140.76
-4032.15
-503.96
2903.63
3144.14
Operating Profit Margin (Excl OI)
-4.53%
-26.34%
4.06%
-25.92%
3.22%
15.96%
13.39%
Gross Profit Margin
-10.03%
-20.81%
30.57%
-24.94%
7.46%
21.6%
12.21%
PAT Margin
-20.49%
-47.37%
-1.05%
-30.76%
-5.07%
10.54%
7.31%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - QoQ
stock-summary

Net Sales

QoQ Growth in quarter ended Jun 2023 is 39.07% vs -28.67% in Mar 2023

stock-summary

Consolidate Net Profit

QoQ Growth in quarter ended Jun 2023 is 39.85% vs -3,117.91% in Mar 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

QoQ Growth in quarter ended Jun 2023 is 3,621.06% vs -99.56% in Mar 2023

stock-summary

Interest

QoQ Growth in quarter ended Jun 2023 is 29.91% vs 7.74% in Mar 2023

stock-summary

Operating Profit Margin (Excl OI)

QoQ Growth in quarter ended Jun 2023 has improved from Mar 2023

Compare Quarterly Results Of DANAMECO Medical JSC With
Markets Mojo
Figures in Million
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(VND)
Change(%)
Net Sales
69,857.20
0
69,857.20
Other Operating Income
0.00
0.00
0.00
Total Operating income
69,857.20
0
69,857.20
Raw Material Cost
64,541.77
0
64,541.77
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
4,822.00
0
4,822.00
Selling and Distribution Expenses
8,483.24
0
8,483.24
Other Expenses
-482.20
0.00
-482.20
Total Expenditure (Excl Depreciation)
73,025.01
0
73,025.01
Operating Profit (PBDIT) excl Other Income
-3,167.81
0.00
-3,167.81
Other Income
-6,322.18
0
-6,322.18
Operating Profit (PBDIT)
-2,188.12
0
-2,188.12
Interest
4,822.00
0
4,822.00
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
5,315.43
0
5,315.43
Depreciation
7,301.86
0
7,301.86
Profit Before Tax
-14,311.99
0
-14,311.99
Tax
0.00
0
0.00
Provisions and contingencies
0.00
0
0.00
Profit After Tax
-14,311.99
0
-14,311.99
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
-14,311.99
0
-14,311.99
Share in Profit of Associates
0.00
0
0.00
Minority Interest
0.00
0
0.00
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-14,311.99
0
-14,311.99
Equity Capital
0
0
0.00
Face Value
10,000.00
0
0.00
Reserves
4,496.77
0
4,496.77
Earnings per share (EPS)
-2,724.50
0
-2,724.50
Diluted Earnings per share
-2,724.50
0
-2,724.50
Operating Profit Margin (Excl OI)
-4.53%
0%
0.00
-4.53%
Gross Profit Margin
-10.03%
0%
0.00
-10.03%
PAT Margin
-20.49%
0%
0.00
-20.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 6,985.72 Million
in Jun 2023

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2023 is 39.07% vs -28.67% in Mar 2023

stock-summary

YoY Growth in quarter ended Jun 2023 is 33.81% vs -29.10% in Jun 2022

Quarterly - Consolidate Net Profit
Consolidate Net Profit -1,431.20 Million
in Jun 2023

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2023 is 39.85% vs -3,117.91% in Mar 2023

stock-summary

YoY Growth in quarter ended Jun 2023 is -440.61% vs -11,918.75% in Jun 2022

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 413.41 Million
in Jun 2023

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2023 is 3,621.06% vs -99.56% in Mar 2023

stock-summary

YoY Growth in quarter ended Jun 2023 is -49.73% vs 85.02% in Jun 2022

Quarterly - Interest
Interest 482.20 Million
in Jun 2023

Figures in Million
stock-summary

QoQ Growth in quarter ended Jun 2023 is 29.91% vs 7.74% in Mar 2023

stock-summary

YoY Growth in quarter ended Jun 2023 is 23.88% vs -14.13% in Jun 2022

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) -4.53%
in Jun 2023

Figures in %
stock-summary

QoQ Growth in quarter ended Jun 2023 has improved from Mar 2023

stock-summary

YoY Growth in quarter ended Jun 2023 has fallen from Jun 2022